Mapi Pharma Ltd.   Report issue

For profit Phase 3
Founded: Ness Ziona Israel (2008)
Status: Acquired by ICON (2017)

Organization Overview

First Clinical Trial
2014
NCT02212886
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Coordinating PI | MAPI Group | Mapi Pharma Ltd.